Mark Hartmann
Impact in
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
- Physiology top 5%
- Nitric Oxide and Endothelin Effects
Papers in
-
- RNA modifications and cancer 6
- Epigenetics and DNA Methylation 6
- Cancer-related gene regulation 3
- Single-cell and spatial transcriptomics 1
-
- Nitric Oxide and Endothelin Effects 3
- Co-authors
- Ulrich Förstermann (3 shared papers)Thomas Münzel (3 shared papers)Mathias Oelze (3 shared papers)Hanke Mollnau (3 shared papers)Thomas Meinertz (3 shared papers)Ascan Warnholtz (3 shared papers)Ulrich Hink (2 shared papers)M. Skatchkov (2 shared papers)
- Journals
- Circulation Research (2 papers)International Journal of Cancer (2 papers)Clinical Cancer Research (1 paper)Wiley Interdisciplinary Reviews - RNA (1 paper)Cell Cycle (1 paper)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Mark Hartmann
13 papers receiving 1.5k citations
Mark Hartmann's Hit Papers
Peers
Comparison fields: 5 of 89
- Biochemistry 198
- Physiology 696
- Clinical Biochemistry 173
- Cardiology and Cardiovascular Medicine 374
- Endocrinology, Diabetes and Metabolism 193
Countries citing papers authored by Mark Hartmann
This map shows the geographic impact of Mark Hartmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hartmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hartmann more than expected).
Fields of papers citing papers by Mark Hartmann
This network shows the impact of papers produced by Mark Hartmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hartmann. The network helps show where Mark Hartmann may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Hartmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus Hit paper breakdown → | 2001 | 965 |
| 2 | 2000 | 184 | |
| 3 | 2017 | 133 | |
| 4 | 2015 | 79 | |
| 5 | 2018 | 57 | |
| 6 | 2000 | 35 | |
| 7 | 2020 | 31 | |
| 8 | 2022 | 13 | |
| 9 | 2017 | 9 | |
| 10 | 2024 | 8 | |
| 11 | 2018 | 3 | |
| 12 | Max-Balanced Flows | 1990 | 2 |
| 13 | 2022 | 1 |
About Mark Hartmann
Mark Hartmann is a scholar working on Molecular Biology, Physiology, Immunology, Cardiology and Cardiovascular Medicine and Hematology, having authored 13 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (6 papers), Epigenetics and DNA Methylation (6 papers), Nitric Oxide and Endothelin Effects (3 papers), Cancer-related gene regulation (3 papers), Acute Myeloid Leukemia Research (2 papers), Single-cell and spatial transcriptomics (1 paper), interferon and immune responses (1 paper) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Biochemistry (198 citations), Physiology (696 citations), Clinical Biochemistry (173 citations), Cardiology and Cardiovascular Medicine (374 citations) and Endocrinology, Diabetes and Metabolism (193 citations). Mark Hartmann has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Ulrich Förstermann, Thomas Münzel, Mathias Oelze, Hanke Mollnau, Thomas Meinertz, Ascan Warnholtz, Ulrich Hink, M. Skatchkov, Huige Li and Kathy K. Griendling. Their work appears in journals such as Circulation Research, International Journal of Cancer, Clinical Cancer Research, Wiley Interdisciplinary Reviews - RNA and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.